Document is current
Any future updates will be listed below
-
Authors
Dupuy, Pierre https://orcid.org/0000-0002-7451-304X
Ghosh, Shreya https://orcid.org/0000-0002-1709-8011
Adefisayo, Oyindamola
Buglino, John
Shuman, Stewart
Glickman, Michael S. https://orcid.org/0000-0001-7918-5164
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI064693)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA008748)
- License Information
-
More Information
Article History
Received: 17 March 2022
Accepted: 12 July 2022
First Online: 2 August 2022
Competing interests
: M.S.G. has received consulting fees from Vedanta Biosciences, PRL NYC, and Fimbrion Therapeutics and has equity in Vedanta biosciences. All other authors declare no competing interests.
